CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
47 hedge funds and large institutions have $28M invested in CTI BioPharma Corp. (DE) Common Stock in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-11
Holders Change %
-18.97%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
11
Reduced
14
Closed
17
Calls
$299K
Puts
–
Net Calls
+$299K
Net Calls Change
+$266K
Top Buyers
| 1 |
BlackRock
New York
|
+$1.49M |
| 2 |
Millennium Management
New York
|
+$479K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$224K |
| 4 |
Morgan Stanley
New York
|
+$224K |
| 5 |
Jane Street
New York
|
+$201K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.07M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$384K |
| 3 |
Goldman Sachs
New York
|
-$263K |
| 4 |
Renaissance Technologies
New York
|
-$230K |
| 5 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$145K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BF
51
BOK Financial
Tulsa,
Oklahoma
| – | -$6K | -1,500 | Closed |
|
52
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$6K | -1,370 | Closed |
|
53
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$5K | -1,150 | Closed |
|